PUBLICATIONS

Dual antiplatelet therapy (PEGASUS) vs. dual pathway (COMPASS): a head-to-head in vitro comparison

No.84
CitationPlatelets. Apr 15:1-6 (2021)
InstituteUniversity of Ottawa Heart Institute, Canada
1st AuthorCR Clifford
AR
PL
HD
Paper typesBasic research
Main
purpose
Provide a first in vitro comparison of DAPT versus Dual Pathway(DP) approach at clinically proven doses
Disease
Antiplatelet drugaspirin, ticagrelor
Anticoagulant drugrivaroxaban
Other drug
Clinical specimens
Animal
KeywordDirect oral anticoagulants; dual antiplatelet therapy; myocardial infarction; percutaneous coronary intervention; total thrombus analysis system
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2021 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.